Awards, press coverage, papers and preprints from our lab.
2026 Recognition
Awards & honors
2026
American College of Gastroenterology
Dr. Daniel Matloff receives ACG Outstanding Poster Presenter Award
Congratulations to Gubatan Lab research trainee Dr. Daniel Matloff for receiving the American College of Gastroenterology Outstanding Poster Presenter Award for his project, “Clinical Outcomes After TNF Inhibitor Initiation in Patients With Inflammatory Bowel Disease and Prior Ustekinumab Exposure.”
September 28, 2026
Clinician Unleashed for Research Excellence
CURE 2030 funding for EoSPACE-IBD
“EoSPACE-IBD: Spatial Eosinophil Niches to Decipher Inflammation and Fibrosis in IBD” has been selected for funding through the Clinician Unleashed for Research Excellence (CURE 2030) Program.
June 11, 2026
Stimulating and Advancing Research in DOM
STARDOM Award
“Fructose Hyperabsorption Phenotype and Multicompartment Microbiome Dysbiosis in MASLD - a Precure Precision Medicine Approach” was selected for STARDOM (Stimulating and Advancing Research in DOM) funding.
August 2026
Emulate Organoid Gut-on-Chip
2026 Florida Translational Capital Equipment Award
Dr. John Gubatan is part of the award team for an Emulate Organoid Gut-on-Chip platform to model inflammatory and metabolic gastrointestinal diseases using patient-derived intestinal organoids under physiologic flow. His contribution focuses on inflammatory bowel disease.
A single-cell blood atlas links B- and T-cell receptor features to coordinated immune programs in inflammatory bowel disease, creating a resource for studying adaptive immune states.
Our collaborative immuneML work introduces reproducible workflows for discovering structure in adaptive immune receptor datasets, including clustering and generative modeling.
Our multi-omics study connects vitamin D treatment with changes in antibody-coated gut bacteria and immune pathways associated with tolerance in inflammatory bowel disease.